These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31658437)
1. Associations of plasma IGF1, IGFBP3 and estradiol with leucocyte telomere length, a marker of biological age, in men. Yeap BB; Hui J; Knuiman MW; S A Paul C; Ken K Y H; Flicker L; Divitini ML; Arscott GM; Twigg SM; Almeida OP; Hankey GJ; Golledge J; Beilby JP Eur J Endocrinol; 2020 Jan; 182(1):23-33. PubMed ID: 31658437 [TBL] [Abstract][Full Text] [Related]
2. Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study. Yeap BB; Chubb SA; McCaul KA; Ho KK; Hankey GJ; Norman PE; Flicker L Eur J Endocrinol; 2011 May; 164(5):715-23. PubMed ID: 21378090 [TBL] [Abstract][Full Text] [Related]
3. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. Yeap BB; Chubb SA; Ho KK; Setoh JW; McCaul KA; Norman PE; Jamrozik K; Flicker L Eur J Endocrinol; 2010 Feb; 162(2):249-57. PubMed ID: 19917654 [TBL] [Abstract][Full Text] [Related]
4. Cross-sectional associations of sex hormones with leucocyte telomere length, a marker of biological age, in a community-based cohort of older men. Yeap BB; Hui J; Knuiman MW; Handelsman DJ; Flicker L; Divitini ML; Arscott GM; McLennan SV; Twigg SM; Almeida OP; Hankey GJ; Golledge J; Norman PE; Beilby JP Clin Endocrinol (Oxf); 2019 Apr; 90(4):562-569. PubMed ID: 30561819 [TBL] [Abstract][Full Text] [Related]
5. Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1. Chan YX; Alfonso H; Paul Chubb SA; Ho KKY; Gerard Fegan P; Hankey GJ; Golledge J; Flicker L; Yeap BB Clin Endocrinol (Oxf); 2018 Feb; 88(2):333-340. PubMed ID: 29044573 [TBL] [Abstract][Full Text] [Related]
6. Associations of IGF1 and its binding proteins with abdominal aortic aneurysm and aortic diameter in older men. Yeap BB; Chubb SA; McCaul KA; Flicker L; Ho KK; Golledge J; Hankey GJ; Norman PE Eur J Endocrinol; 2012 Feb; 166(2):191-7. PubMed ID: 22113073 [TBL] [Abstract][Full Text] [Related]
8. Associations of insulin-like growth factor-I and its binding proteins and testosterone with frailty in older men. Yeap BB; Paul Chubb SA; Lopez D; Ho KK; Hankey GJ; Flicker L Clin Endocrinol (Oxf); 2013 May; 78(5):752-9. PubMed ID: 23009592 [TBL] [Abstract][Full Text] [Related]
9. Serum testosterone and sex hormone-binding globulin are inversely associated with leucocyte telomere length in men: a cross-sectional analysis of the UK Biobank study. Marriott RJ; Murray K; Budgeon CA; Codd V; Hui J; Arscott GM; Beilby JP; Hankey GJ; Wittert GA; Wu FCW; Yeap BB Eur J Endocrinol; 2023 Feb; 188(2):. PubMed ID: 36751991 [TBL] [Abstract][Full Text] [Related]
10. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk. Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071 [TBL] [Abstract][Full Text] [Related]
11. Atorvastatin administration is associated with dose-related changes in IGF bioavailability. Narayanan RP; Gittins M; Siddals KW; Oliver RL; Hudson JE; White A; Durrington P; Davies RR; Rutter MK; Gibson JM Eur J Endocrinol; 2013 Apr; 168(4):543-8. PubMed ID: 23333902 [TBL] [Abstract][Full Text] [Related]
12. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors and leukocyte telomere length: the cardiovascular health study. Kaplan RC; Fitzpatrick AL; Pollak MN; Gardner JP; Jenny NS; McGinn AP; Kuller LH; Strickler HD; Kimura M; Psaty BM; Aviv A J Gerontol A Biol Sci Med Sci; 2009 Nov; 64(11):1103-6. PubMed ID: 19349587 [TBL] [Abstract][Full Text] [Related]
14. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS; PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909 [TBL] [Abstract][Full Text] [Related]
15. Evidence of different actions of testosterone, estradiol, FSH, and LH on the growth axis. Ruiz E; Osorio A; Torres JM; Ortega E Endocr Res; 2001; 27(1-2):25-33. PubMed ID: 11428716 [TBL] [Abstract][Full Text] [Related]
16. Circulating IGF1 and IGFBP3 in relation to the development of β-cell autoimmunity in young children. Peet A; Hämäläinen AM; Kool P; Ilonen J; Knip M; Tillmann V; Eur J Endocrinol; 2015 Aug; 173(2):129-37. PubMed ID: 25947142 [TBL] [Abstract][Full Text] [Related]
17. Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study. Isotton AL; Wender MC; Casagrande A; Rollin G; Czepielewski MA Eur J Endocrinol; 2012 Feb; 166(2):207-13. PubMed ID: 22108915 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adults. Vestergaard PF; Hansen M; Frystyk J; Espelund U; Christiansen JS; Jørgensen JO; Fisker S Eur J Endocrinol; 2014 Feb; 170(2):229-36. PubMed ID: 24179101 [TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population. Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087 [TBL] [Abstract][Full Text] [Related]
20. IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort. Verheus M; Maskarinec G; Woolcott CG; Haiman CA; Le Marchand L; Henderson BE; Cheng I; Kolonel LN Int J Cancer; 2010 Sep; 127(5):1115-23. PubMed ID: 20039319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]